サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1373917

子宮がん治療・診断市場：タイプ別、治療法別、主要検査別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測

Uterine Cancer Therapies and Diagnostic Market, By Type, By Treatment, By Major Tests, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 302 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
子宮がん治療・診断市場：タイプ別、治療法別、主要検査別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
出版日: 2023年10月01日
発行: AnalystView Market Insights
ページ情報: 英文 302 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートのハイライト

子宮がん治療と診断の市場規模は2022年に220億6,190万米ドルとなり、2023年から2030年にかけてCAGR 6.3％で拡大

子宮がん治療・診断市場-市場力学

子宮がんに対する認識と技術革新が市場成長の原動力となる見込み

ヘルスケア専門家や患者は現在、子宮体がんの有病率を認識しており、さらに子宮体がんの治療に利用可能な治療法について積極的に学ぶようになっています。これに伴い、世界市場における子宮体がん治療および診断の主な顕著な要因となっています。しかし、高価な治療手順や副作用は、市場の成長を妨げる主な要因の一部です。さらに、子宮体がん治療・診断市場は、都市人口のヘルスケア支出の大幅な増加や、より良いヘルスケアインフラのための政府の取り組みによって活性化されています。さらに、医療サービスにおける技術革新や子宮がんに関する新薬の導入の成果として、患者は適切な治療や診断に投資するよう奨励されています。

子宮体がん治療・診断市場-主要インサイト

弊社のリサーチアナリストの分析によると、世界の子宮体がん治療・診断市場は、市場推計・予測期間（2023-2030年）においてCAGR約6.3%で年間成長すると予測されています。

子宮体がん治療と診断産業は、子宮内膜腺がんの負担の増加により、著しい速度で成長すると予測されます。

タイプ別セグメンテーションでは、子宮内膜がんが2022年に最大の市場シェアを示すと予測されました。

治療法のセグメンテーションに基づくと、化学療法が2022年に主要なタイプでした。

子宮内膜がんの発生率増加の主な要因は、女性の肥満の増加であり、市場成長を加速させると予測されます。

子宮体がん治療・診断市場-セグメンテーション分析：

世界の子宮体がん治療・診断市場は、タイプ、治療法、主要検査、地域に基づいて区分されます。

子宮内膜がんと子宮肉腫です。子宮内膜がんセグメントは、予測期間中に最も高い市場シェアを占めると思われます。子宮内膜に発生する子宮体がんは、子宮体がん特有の分類の1つです。リキッドバイオプシーや最先端のイメージング技術など、子宮内膜がんに特化した診断技術やツールの進歩を評価することで、このセグメントにおける診断市場の洞察が得られます。

市場は治療法に基づき、免疫療法、手術療法、化学療法、経過観察療法、放射線療法の5つのカテゴリーに分類されます。化学療法は、特に転移性または進行性の子宮体がん治療において不可欠な要素であるため、化学療法分野が最も高い市場シェアを占める。化学療法物質は、急速に分裂するがん細胞を死滅させたり、成長を遅らせたりするために利用されます。

子宮体がん治療・診断市場-地理的洞察

子宮体がん治療薬および診断薬市場は、北米が将来的に優位を占めるとみられます。この地域の市場成長の主な理由は、一般人口の間での意識の高まりと罹患率の上昇です。さらに、経済における新技術の迅速な採用が、研究された市場の全体的な成長を後押ししています。さらに、欧州地域は、これらの国の女性のライフスタイルの変化により、市場を独占することを占めています。高齢の女性では、子宮体がんの有病率が高いです。

子宮体がん治療・診断市場-競合情勢：

子宮体がん治療・診断市場は競争が激しく、複数の医療機器メーカー、製薬企業、研究機関が積極的に参入しています。診断・治療技術の進歩や新規参入が市場に影響を与え続けています。さらに、がん治療や検診を支援する政府の取り組みやヘルスケア政策が、子宮がん治療・診断市場全体の成長を後押ししています。腫瘍学の分野では、進行中の研究開発活動が診断ツールや革新的な治療法の開発につながります。例えば、2023年6月、ファイザー社は、エストロゲンベースの更年期ホルモン療法であるDUAVEE（R）が、自主回収の後、より良いパッケージで米国に再入荷したと発表しました。このリコールは、包装に問題があったためで、製品自体の安全性や有効性に関する懸念に基づくものではありません。

目次

第1章 子宮がんの治療および診断市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 子宮がん治療および診断の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 子宮がん治療と診断産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 子宮がんの治療および診断市場：COVID-19症の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 子宮がん治療と診断市場情勢

  • 子宮がん治療および診断市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 子宮がんの治療および診断市場- 種類別

  • 概要
    • タイプ別セグメントシェア分析
    • 子宮内膜がん
    • 子宮肉腫

第8章 子宮がんの治療および診断市場- 治療別

  • 概要
    • 治療別セグメントシェア分析
    • 免疫療法
    • 手術
    • 化学療法
    • フォローアップ治療
    • 放射線治療

第9章 子宮がんの治療および診断市場- 主要検査別

  • 概要
    • セグメントシェア分析、主要テスト別
    • 子宮鏡検査
    • 生検
    • 骨盤超音波検査
    • CTスキャン
    • 拡張と掻爬

第10章 子宮がんの治療法と診断市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 子宮がん治療および診断産業

  • 競合ダッシュボード
  • 企業プロファイル
    • Ariad Pharmaceuticals
    • AstraZeneca PLC
    • Siemens Healthcare Inc.
    • Abbott Laboratories
    • Eli Lilly and Company
    • Becton Dickinson &co
    • Roche Ltd.
    • GlaxoSmithKline Plc
    • Ability Pharma
    • Merck &Co.
    • BioMerieux SA
    • Novartis AG
    • F. Hoffmann-La Roche AG
    • Sanofi

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Uterine Cancer Therapies and Diagnostic Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Uterine Cancer Therapies and Diagnostic Market, by Type2018-2030 (USD Million)
  • TABLE Uterine Cancer Therapies and Diagnostic Market: TreatmentSnapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Treatment
  • TABLE Global Uterine Cancer Therapies and Diagnostic Market, by Treatment2018-2030 (USD Million)
  • TABLE Uterine Cancer Therapies and Diagnostic Market: Major tests Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Major tests
  • TABLE Global Uterine Cancer Therapies and Diagnostic Market, by Major tests 2018-2030 (USD Million)
  • TABLE Uterine Cancer Therapies and Diagnostic Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Uterine Cancer Therapies and Diagnostic Market, by Region 2018-2030 (USD Million)
  • TABLE North America Uterine Cancer Therapies and Diagnostic Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Uterine Cancer Therapies and Diagnostic Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Uterine Cancer Therapies and Diagnostic Market, by Treatment, 2018-2030 (USD Million)
  • TABLE North America Uterine Cancer Therapies and Diagnostic Market, by Major tests, 2018-2030 (USD Million)
  • TABLE Europe Uterine Cancer Therapies and Diagnostic Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Uterine Cancer Therapies and Diagnostic Market, by Type, 2018-2030 (USD Million)
  • TABLE Europe Uterine Cancer Therapies and Diagnostic Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Europe Uterine Cancer Therapies and Diagnostic Market, by Major tests, 2018-2030 (USD Million)
  • TABLE Asia Pacific Uterine Cancer Therapies and Diagnostic Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Uterine Cancer Therapies and Diagnostic Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Uterine Cancer Therapies and Diagnostic Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Asia Pacific Uterine Cancer Therapies and Diagnostic Market, by Major tests, 2018-2030 (USD Million)
  • TABLE Latin America Uterine Cancer Therapies and Diagnostic Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Uterine Cancer Therapies and Diagnostic Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Uterine Cancer Therapies and Diagnostic Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Latin America Uterine Cancer Therapies and Diagnostic Market, by Major tests, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Uterine Cancer Therapies and Diagnostic Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Uterine Cancer Therapies and Diagnostic Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Uterine Cancer Therapies and Diagnostic Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Uterine Cancer Therapies and Diagnostic Market, by Major tests, 2018-2030 (USD Million)

List of Figures

  • FIGURE Uterine Cancer Therapies and Diagnostic Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Type segment market share analysis, 2022&2030
  • FIGURE Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Treatment segment market share analysis, 2022&2030
  • FIGURE Treatment segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Major tests segment market share analysis, 2022&2030
  • FIGURE Major tests segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022&2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Uterine Cancer Therapies and Diagnostic Market share and leading players, 2022
  • FIGURE Europe Uterine Cancer Therapies and Diagnostic Market share and leading players, 2022
  • FIGURE Asia Pacific Uterine Cancer Therapies and Diagnostic Market share and leading players, 2022
  • FIGURE Latin America Uterine Cancer Therapies and Diagnostic Market share and leading players, 2022
  • FIGURE Middle East and Africa Uterine Cancer Therapies and Diagnostic Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Uterine Cancer Therapies and Diagnostic Market share analysis by country, 2022
  • FIGURE Germany Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Uterine Cancer Therapies and Diagnostic Market share analysis by country, 2022
  • FIGURE India Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Uterine Cancer Therapies and Diagnostic Market share analysis by country, 2022
  • FIGURE Brazil Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Uterine Cancer Therapies and Diagnostic Market share analysis by country, 2022
  • FIGURE Saudi Arabia Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Uterine Cancer Therapies and Diagnostic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1805

REPORT HIGHLIGHT

Uterine cancer therapies and diagnostic market size was valued at USD 22,061.9 Million in 2022, expanding at a CAGR of 6.3% from 2023 to 2030.

Uterine cancer is a cancer that affects the female reproductive system. It is a malignant tumor that starts in the uterus cells and has the potential to spread to other body parts. Uterine cancer therapeutics primarily includes numerous treatment modalities, such as radiation therapy, hormone therapy, targeted therapy, chemotherapy, and surgery. Additionally, the treatment choice depends on various factors such as the patient's overall health, the type of uterine cancer, and the stage of the cancer.

Uterine Cancer Therapies and Diagnostic Market- Market Dynamics

Awareness of uterine cancer and technical innovations are expected to drive market growth

Healthcare professionals and patients are now aware of the prevalence of uterine cancer, and additionally becoming more actively interested in learning about the therapies available for the treatment of these conditions. In line with this, this is the main prominent factor for uterine cancer therapies and diagnostics in the global market. However, costly treatment procedures and adverse side effects are some of the major factors likely to hinder market growth. Furthermore, the market for uterine cancer therapies and diagnostics is being fueled by the significant increment in healthcare spending among the urban population and government initiatives for better healthcare infrastructure. Moreover, patients are being encouraged to invest in proper treatments and diagnostics as an outcome of technical innovations in healthcare services and the introduction of novel drugs regarding uterine cancer.

Uterine Cancer Therapies and Diagnostic Market- Key Insights

As per the analysis shared by our research analyst, the global uterine cancer therapies and diagnostic market is estimated to grow annually at a CAGR of around 6.3% over the forecast period (2023-2030)

The uterine cancer therapies and diagnostic industry is projected to grow at a significant rate due to the growing burden of endometrial adenocarcinoma.

Based on type segmentation, endometrial carcinomas was predicted to show maximum market share in the year 2022

Based on treatments segmentation, chemotherapy was the leading type in 2022

The prime factor responsible for the growing incidence of endometrium carcinoma is increasing obesity among women is projected to accelerate the market growth.

Uterine Cancer Therapies and Diagnostic Market- Segmentation Analysis:

The global uterine cancer therapies and diagnostic market is segmented on the basis of type, treatment, major tests, and region.

The market is divided into two categories based on type: endometrial carcinomas and uterine sarcomas. The endometrial carcinomas segment is likely to dominate the highest market share during the forecast period. One of the unique categories of uterine cancer that occurs in the lining of the uterus is endometrial carcinoma. Assessing advancements in diagnostic techniques and tools specific to endometrial carcinomas, including liquid biopsies or cutting-edge imaging technologies, offers insights into the diagnostic market within this segment.

The market is divided into five categories based on treatments: immunotherapy, surgery, chemotherapy, follow-up treatment, and radiation therapy. The chemotherapy segment is accounted to grow with the highest market share as chemotherapy is an essential component of uterine cancer treatment, particularly for metastatic or advanced cases. Chemotherapeutic substances are utilized to kill or to slow down the growth of the rapidly dividing cancer cells

Uterine Cancer Therapies and Diagnostic Market- Geographical Insights

North America is likely to dominate the uterine cancer therapeutics and diagnostics market in the future. The growing awareness and rising incidence among the general population is the prime reason for the market growth in this region. Additionally, faster adoption of new technologies in the economy is boosting the overall growth of the market studied. Moreover, the European region is accounted to dominate the market due to the changing lifestyles of women in these countries. In aged women prevalence of uterine cancer is more common.

Uterine Cancer Therapies and Diagnostic Market- Competitive Landscape:

The uterine cancer therapeutic and diagnostic market is highly competitive, with several medical device manufacturers, pharmaceutical companies, and research institutions actively participating. Advancements in diagnostic and therapeutic technologies and new entrants continue to influence the market. Additionally, for cancer treatment and screening supportive government initiatives and healthcare policies, boost the overall market growth of the uterine cancer therapeutic and diagnostic. In the field of oncology, ongoing research and development activities lead to the development of diagnostic tools and innovative therapies. For instance, in June 2023, Pfizer Inc. announced that DUAVEE® an estrogen-based menopause hormone therapy, is now back in stock in the United States, with better packaging, following a voluntary recall. The recall was due to a concern with the packaging and was not based on any safety and efficacy concerns with the product itself.

Recent Developments:

For instance, in April 2021, Roche announced the U.S. Food and Drug Administration (FDA) approval of the VENTANA MMR RxDx Panel for advanced or recurrent endometrial cancer patients. Testing can examine patients eligible for treatment with JEMPERLI (dostarlimab-gxly) monotherapy, an anti-PD1 immunotherapy from GlaxoSmithKline (GSK) that was approved by the FDA.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL UTERINE CANCER THERAPIES AND DIAGNOSTIC MARKET KEY PLAYERS

  • Ariad Pharmaceuticals
  • AstraZeneca PLC
  • Siemens Healthcare Inc.
  • Abbott Laboratories
  • Eli Lilly and Company
  • Becton Dickinson & co
  • Roche Ltd.
  • GlaxoSmithKline Plc
  • Ability Pharma
  • Merck & Co.
  • BioMerieux S.A.
  • Novartis AG
  • F. Hoffmann-La Roche AG
  • Sanofi

GLOBAL UTERINE CANCER THERAPIES AND DIAGNOSTIC MARKET, BY TYPE

  • Endometrial carcinomas
  • Uterine sarcomas

GLOBAL UTERINE CANCER THERAPIES AND DIAGNOSTIC MARKET, BY TREATMENT

  • Immunotherapy
  • Surgery
  • Chemotherapy
  • Follow-up Treatment
  • Radiation therapy

GLOBAL UTERINE CANCER THERAPIES AND DIAGNOSTIC MARKET, BY MAJOR TESTS

  • Hysteroscopy
  • Biopsy
  • Pelvic Ultrasound
  • CT Scan
  • Dilation and curettage
  • Others

GLOBAL UTERINE CANCER THERAPIES AND DIAGNOSTIC MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Uterine Cancer Therapies and Diagnostic Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Uterine Cancer Therapies and Diagnostic Market Snippet by Type
    • 2.1.2. Uterine Cancer Therapies and Diagnostic Market Snippet by Treatment
    • 2.1.3. Uterine Cancer Therapies and Diagnostic Market Snippet by Major tests
    • 2.1.4. Uterine Cancer Therapies and Diagnostic Market Snippet by Country
    • 2.1.5. Uterine Cancer Therapies and Diagnostic Market Snippet by Region
  • 2.2. Competitive Insights

3. Uterine Cancer Therapies and Diagnostic Key Market Trends

  • 3.1. Uterine Cancer Therapies and Diagnostic Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Uterine Cancer Therapies and Diagnostic Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Uterine Cancer Therapies and Diagnostic Market Opportunities
  • 3.4. Uterine Cancer Therapies and Diagnostic Market Future Trends

4. Uterine Cancer Therapies and Diagnostic Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Uterine Cancer Therapies and Diagnostic Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Uterine Cancer Therapies and Diagnostic Market Landscape

  • 6.1. Uterine Cancer Therapies and Diagnostic Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Uterine Cancer Therapies and Diagnostic Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022&2030 (%)
    • 7.1.2. Endometrial carcinomas
    • 7.1.3. Uterine sarcomas

8. Uterine Cancer Therapies and Diagnostic Market - By Treatment

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Treatment, 2022&2030 (%)
    • 8.1.2. Immunotherapy
    • 8.1.3. Surgery
    • 8.1.4. Chemotherapy
    • 8.1.5. Follow-up Treatment
    • 8.1.6. Radiation therapy

9. Uterine Cancer Therapies and Diagnostic Market - By Major tests

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Major tests, 2022&2030 (%)
    • 9.1.2. Hysteroscopy
    • 9.1.3. Biopsy
    • 9.1.4. Pelvic Ultrasound
    • 9.1.5. CT Scan
    • 9.1.6. Dilation and curettage

10. Uterine Cancer Therapies and Diagnostic Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Uterine Cancer Therapies and Diagnostic Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Uterine Cancer Therapies and Diagnostic Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Uterine Cancer Therapies and Diagnostic Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Uterine Cancer Therapies and Diagnostic Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Uterine Cancer Therapies and Diagnostic Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Major tests, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Uterine Cancer Therapies and Diagnostic Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Ariad Pharmaceuticals
    • 11.2.2. AstraZeneca PLC
    • 11.2.3. Siemens Healthcare Inc.
    • 11.2.4. Abbott Laboratories
    • 11.2.5. Eli Lilly and Company
    • 11.2.6. Becton Dickinson & co
    • 11.2.7. Roche Ltd.
    • 11.2.8. GlaxoSmithKline Plc
    • 11.2.9. Ability Pharma
    • 11.2.10. Merck & Co.
    • 11.2.11. BioMerieux S.A.
    • 11.2.12. Novartis AG
    • 11.2.13. F. Hoffmann-La Roche AG
    • 11.2.14. Sanofi

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us